Home Laurus Labs Limited

Laurus Labs Limited

Profile managed by Bizz Id

India 500+ employees 2005

Description

Laurus Labs Limited is an Indian pharmaceutical and biotechnology company incorporated in 2005, headquartered in Hyderabad, with manufacturing and R&D concentrated in Visakhapatnam (Andhra Pradesh), Hyderabad, Bengaluru and Mumbai. Its main business is the development and large-scale manufacture of active pharmaceutical ingredients and advanced intermediates, where it ranks among the world's leading suppliers of antiretrovirals, alongside cardiovascular, central nervous system, oncology and other generic molecules. It also manufactures finished dosage forms for the global-health institutional market and for regulated markets, and runs a CDMO business for innovator companies. Through Laurus Bio it operates microbial and precision fermentation for life-science, nutrition and industrial customers. It reports 15 manufacturing sites, 8,126 employees and 92 cumulative DMF filings as of FY 2025-26. Laurus does not publish its API list; it provides it on request. The products shown on this profile are the finished dosage forms marketed by its US subsidiary.

Products

17 products

Abacavir and Lamivudine Tablets, USP

Tablets 600 mg/300 mg. Antiretroviral; generic equivalent of Epzicom.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Abacavir: see suppliers → · Lamivudine: see suppliers →

Atazanavir Capsules

Capsules 150 mg, 200 mg and 300 mg. Antiretroviral; generic equivalent of Reyataz.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Atazanavir: see suppliers →

Atorvastatin Calcium Tablets, USP

Tablets 10, 20, 40 and 80 mg. Antilipidemic; generic equivalent of Lipitor.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Atorvastatin: see suppliers →

Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Tablets

Tablets 600/200/300 mg. Antiretroviral; generic equivalent of Atripla.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Efavirenz: see suppliers → · Tenofovir Disoproxil: see suppliers →

Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets

Tablets 600/300/300 mg and 400/300/300 mg. Antiretroviral; generic equivalents of Symfi and Symfi LO.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Efavirenz: see suppliers → · Tenofovir Disoproxil: see suppliers →

Emtricitabine and Tenofovir Disoproxil Fumarate Tablets

Tablets 200 mg/300 mg. Antiretroviral; generic equivalent of Truvada.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Emtricitabine: see suppliers → · Tenofovir Disoproxil: see suppliers →

Emtricitabine, Rilpivirine and Tenofovir Disoproxil Fumarate Tablets

Tablets 200/25/300 mg. Antiretroviral; generic equivalent of Complera.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Emtricitabine: see suppliers → · Tenofovir Disoproxil: see suppliers →

Lopinavir and Ritonavir Tablets, USP

Tablets 100 mg/25 mg and 200 mg/50 mg. Antiretroviral; generic equivalent of Kaletra.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Lopinavir: see suppliers → · Ritonavir: see suppliers →

Macitentan Tablets

Tablets 10 mg. Cardiovascular; generic equivalent of Opsumit.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Macitentan: see suppliers →

Metformin Hydrochloride Extended-Release Tablets, USP

Extended-release tablets 500 mg and 750 mg. Anti-diabetic; generic equivalent of Glucophage XR.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Metformin: see suppliers →

Metformin Hydrochloride Tablets, USP

Tablets 500, 850 and 1000 mg. Anti-diabetic; generic equivalent of Glucophage.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Metformin: see suppliers →

Oseltamivir Phosphate Capsules, USP

Capsules 75 mg. Antiviral; generic equivalent of Tamiflu.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Oseltamivir: see suppliers →

Pirfenidone Capsules, USP

Capsules 267 mg. Pyridone; generic equivalent of Esbriet.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Pirfenidone: see suppliers →

Pirfenidone Tablets, USP

Tablets 267, 534 and 801 mg. Pyridone; generic equivalent of Esbriet.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Pirfenidone: see suppliers →

Rilpivirine Tablets

Tablets 25 mg. Antiretroviral; generic equivalent of Edurant.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Rilpivirine: see suppliers →

Sacubitril and Valsartan Tablets

Tablets 24/26, 49/51 and 97/103 mg. Angiotensin receptor-neprilysin inhibitor; generic equivalent of Entresto.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Sacubitril: see suppliers → · Valsartan: see suppliers →

Ursodiol Capsules, USP

Capsules 300 mg. Primary biliary cholangitis; generic equivalent of Actigall.

ANDA (EE. UU.)

Filing submitted

Finished product (FDF)

Verified on 2026-10-16

Ursodiol: see suppliers →

Certifications

US FDA WHO EMA PMDA ANVISA MHRA TGA MFDS BfArM (Alemania) ISO 27001:2022

Laurus Labs Limited

Description

Products

Certifications

Contact company